Maxime Dely: The Lifesaving Power of Plasma Donations
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post onย LinkedIn:
”Plasma matters more than we think.
With this 3rd donation of the year, the goal of 10 donations in 2026 remains well on track.
Beyond the gesture itself, each donation helps collect valuable components used every day in medicine.
Among them, fibrinogen plays a central role: this protein is directly involved in blood clotting, transforming into fibrin, which is essential for forming the clot that helps stop bleeding.
Without sufficient fibrinogen, certain medical procedures become far more complex, especially in cases of surgery, trauma, or specific coagulation disorders.
Donating plasma means contributing directly to an essential care chain โ often invisible, yet vital for many patients.
A simple, regular, and meaningful contribution.”
Stay updated withย Hemostasis Today.
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy
-
Jun 25, 2026, 15:23Jonas Kingo: ISTH 2026 in Paris Brings the Global Hemostasis Community Together
-
Jun 25, 2026, 15:21Balancing Therapeutic Progress and Emergency Preparedness in Hemophilia – CRH French Reference Center for Hemophilia Lyon
-
Jun 25, 2026, 15:06Ifeanyichukwu Ifechidere: What If One of the Biggest Myth Fact About APS is Hidden in its Name?
-
Jun 25, 2026, 15:05Gopal Patidar: Advancing Haemovigilance and Global Collaboration at ISBT 2026
-
Jun 25, 2026, 14:52Violeta Jardin: Measuring Antifibrinolytic Effect to Improve Tranexamic Acid Safety